206 results
Page 6 of 11
8-K
EX-99.1
vrwqk2 zhd
12 Aug 20
Results of Operations and Financial Condition
7:32am
8-K
10si9g a4
21 Jul 20
Moleculin Announces New Independent In Vitro Testing Confirms Antiviral Activity of WP1122 in Coronavirus
8:41am
8-K
EX-99.1
9ox7f03
21 Jul 20
Moleculin Announces New Independent In Vitro Testing Confirms Antiviral Activity of WP1122 in Coronavirus
8:41am
8-K
EX-1.1
z3ve7h4
17 Jul 20
Entry into a Material Definitive Agreement
5:19pm
424B5
wspjir deif
17 Jul 20
Prospectus supplement for primary offering
5:16pm
8-K
k3jff8 nm
17 Jun 20
Departure of Directors or Certain Officers
4:20pm
8-K
EX-99.1
nfbc5 gjpw15
16 Jun 20
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
7:32am
8-K
EX-99.1
es6n7855gdpiv
27 May 20
Moleculin Provides Update on Coronavirus Drug Development
5:20pm
8-K
dlkswe
8 Apr 20
Other Events
7:30am
8-K
EX-99.1
kd255ew6
8 Apr 20
Other Events
7:30am
8-K
EX-99.1
wxd78pv
19 Mar 20
Results of Operations and Financial Condition
4:16pm
8-K
EX-99.1
aqw03ojk 0qiuoj9kp
17 Mar 20
Moleculin Signs Agreement with UTMB to Test WP1122 on a Range of Viruses, including Coronavirus
7:31am